We describe a proteomics approach that identifies antigen-specific antibody sequences directly from circulating polyclonal antibodies in the serum of an immunized animal. The approach involves affinity purification of antibodies with high specific activity and then analyzing digested antibody fractions by nano-flow liquid chromatography coupled to tandem mass spectrometry. High-confidence peptide spectral matches of antibody variable regions are obtained by searching a reference database created by next-generation DNA sequencing of the B-cell immunoglobulin repertoire of the immunized animal. Finally, heavy and light chain sequences are paired and expressed as recombinant monoclonal antibodies. Using this technology, we isolated monoclonal antibodies for five antigens from the sera of immunized rabbits and mice. The antigen-specific activities of the monoclonal antibodies recapitulate or surpass those of the original affinity-purified polyclonal antibodies. This technology may aid the discovery and development of vaccines and antibody therapeutics, and help us gain a deeper understanding of the humoral response.
At a glance
- Gene conversion: some implications for immunoglobulin genes. Cell 24, 592–594 (1981).
- Somatic diversification of immunoglobulin heavy chain VDJ genes: evidence for somatic gene conversion in rabbits. Cell 63, 987–997 (1990). &
- Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc. Natl. Acad. Sci. USA 73, 3628–3632 (1976). &
- Antibody diversity: somatic hypermutation of rearranged VH genes. Cell 27, 573–581 (1981). , , , &
- Passive immunity in prevention and treatment of infectious diseases. Clin. Microbiol. Rev. 13, 602–614 (2000). &
- Passive immunity in the prevention of maternal-fetal transmission of human immunodeficiency virus infection. Ann. NY Acad. Sci. 693, 186–193 (1993). &
- Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495–497 (1975). &
- Phage Display: A Laboratory Manual (Cold Spring Harbor Laboratory Press, 2001). , , &
- Using Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory Press, 1998). &
- Human monoclonal antibodies by immortalization of memory B cells. Curr. Opin. Biotechnol. 18, 523–528 (2007). , &
- Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing. J. Mol. Biol. 358, 764–772 (2006). et al.
- Antibody Phage Display: Methods and Protocols (Humana Press, 2002). &
- Hybridoma-free generation of monoclonal antibodies. Proc. Natl. Acad. Sci. USA 101, 257–259 (2004). &
- Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses. F1000 Biol. Rep. 3, 17 <http://f1000.com/reports/b/3/17> (2011). , , &
- Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326, 285–289 (2009). et al.
- Sequencing antibody repertoires: the next generation. MAbs 3, 17–20 (2011).
- The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J. Clin. Oncol. 20, 2310–2318 (2002). et al.
- Restricted utilization of VH and DH genes in leukemic rabbit B cells. Eur. J. Immunol. 20, 397–402 (1990). , &
- Restricted VH gene usage and generation of antibody diversity in rabbit. Annu. Rev. Immunol. 10, 593–616 (1992).
- B cell and antibody repertoire development in rabbits: the requirement of gut-associated lymphoid tissues. Dev. Comp. Immunol. 30, 137–153 (2006). , &
- Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 67, 1426–1436 (1995). , , &
- Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207–214 (2007). &
- A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174–1189 (2010). et al.
- High-throughput DNA sequencing–concepts and limitations. Bioessays 32, 524–536 (2010). &
- Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 36, W465–W469 (2008). et al.
- Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells. Nat. Biotechnol. 28, 965–969 (2010). et al.
- Automated de novo protein sequencing of monoclonal antibodies. Nat. Biotechnol. 26, 1336–1338 (2008). , , , &
- Resurrection of a clinical antibody: template proteogenomic de novo proteomic sequencing and reverse engineering of an anti-lymphotoxin-alpha antibody. Proteomics 11, 395–405 (2011). et al.
- Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75, 663–670 (2003). , &
- The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry. Nat. Protoc. 3, 1630–1638 (2008). &
- A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 24, 1285–1292 (2006). , , , &
- An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 132, 211–250 (1970). &
- Site-specific release of nascent chains from ribosomes at a sense codon. Mol. Cell. Biol. 28, 4227–4239 (2008). et al.
- The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J. Gen. Virol. 82, 1027–1041 (2001). et al.
- A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92, 7297–7301 (1995). et al.
- Supplementary Text and Figures (3 MB)
Supplementary Tables 1–3 and Supplementary Figures 1–8